Clinical Correlative Studies: Active Program Announcements (PA) and Requests for Applications (RFA)
The Cancer Diagnosis Program offers several program announcements to encourage patient-oriented research on new strategies for cancer diagnosis. Some of these announcements are sponsored by the NCI Cancer Therapy Evalution Program to support the integration of translational studies into clinical trials. Investigators may apply for several types of awards in addition to the standard (R01) research project grant.
Current Initiatives (shown in order of publication in the NIH Guide for Grants and Contracts)
| PA-07-021 (R01) | Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis | PA-07-022 (R21) |
| PA-06-299 (R21) | Exploratory Studies in Cancer Detection, Diagnosis, and Prognosis |
| PA-07-177 (R01) PA-06-296 (R21) |
Correlative Studies with Specimens from Multi-Site Trials |
| PA-06-434 (R21/R33) PA-06-435 (R33) |
Phased Innovation Research in Cancer Prognosis and Prediction |
| PAR-08-025 (R21) | Quick-Trials for Novel Cancer Therapies: Exploratory Grants |
Recent Clinical Correlative Studies Funded by CDP provides examples of applications funded in response to these and related prior initiatives.
Information for Grant Applicants: see the Web site of the NCI Office of Technology and Industrial Relations:
Diagnostics Research: New Markers for Prediction and Prognosis
